Stock screener

CAPR

Conviction 69HealthcareScan · Thu, Jun 25, 2026
Bullish engulfing
CAPR$30.42+3.08%
ResistanceSupportVol 14Insider sell
63 bars
2
2
2
Vol MA14 1.23M
Mar 26Apr 14May 1May 19Jun 8Jun 25
CAPRICOR THERAPEUTICS, INC.PHARMACEUTICAL PREPARATIONSwww.capricor.com
Price30.42
Change+3.08%
Gap-0.30%
Rel volume1.97×
Avg volume1.07M
Avg $ vol29.68M
SMA 2027.68
SMA 5030.32
SMA 20021.85
Price vs 50+0.33%
Price vs 200+39.21%
MA stackbullish
50/200 cross
Supertrendup · 25.71
RSI (14)59
MACD hist0.60
MACD crossbull · 5d
Stoch %K / %D92 / 90
ADX (14)19
+DI / −DI26 / 19
RSI divergence
MACD divergenceBullish
ATR %+5.05%
ADR %4.59%
52w high35.34
52w low4.60
From 52w high-13.92%
Above 52w low+561.30%
New 52w highNo
SqueezeOff
Bollinger width23.23%
%B0.93
Donchian pos91.88%
Donchian high30.93
Donchian low24.65
AVWAP (52w high)28.93
vs AVWAP high+5.17%
AVWAP (52w low)27.43
vs AVWAP low+10.88%
OBV trendUp
Chaikin MF (20)-0.08
Today vs 20d1.97×
Avg vol (14d)1.23M
Avg vol (20d)1.07M
Avg $ vol (20d)29.68M
Market cap1.76B
RS 3m (vs SPY)-10.04%
RS 6m (vs SPY)-1.62%
RS line new highNo
Trend template7/8
Technical rank72.7
1 week+8.84%
1 month+3.61%
3 months+1.74%
6 months+3.12%
1 year+228.86%
YTD+7.45%
P/E-16.77
P/B6.32
P/S
P/FCF-24.23
EPS-2.26
Div yield
ROE-37.69%
ROA-32.19%
Debt/Eq
Current8.42
EV/EBITDA-15.59
Gross margin
Net margin
Rev growth-100.00%
EPS growth-159.58%
Price target53.00
Target upside74.23%
Analyst ratingBuy
Institutional63.76%
Ent. value1.66B
Revenue2.26M
Net income-33.94M
Gross profit
Free cash flow-72.72M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out57.91M
Employees231
ListedThu, Jun 20, 2002
Free float41.47M
Float %71.7%
Short interest11.07M
Days to cover14.3d
Short volume61.8%
Squeeze score94 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.59 vs −$0.55
Last surprise-7.3% miss
Setup gradeB
Conviction69 / 100
Pattern quality
Tech rank72.7 / 100
Group rank50 / 100
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmBullish engulfing
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CAPR

All disclosures →
No recent disclosed trades by Congress in CAPR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CAPR · 4 buys · 6 sells

InsiderSideShares
Bergmann Anthony
CHIEF FINANCIAL OFFICER · Common Stock · 2026-06-24
Exercise400
Krasney Karen
EVP, GENERAL COUNSEL · Common Stock · 2026-06-24
Exercise400
Krasney Karen
EVP, GENERAL COUNSEL · Common Stock · 2026-06-24
Sell400
Bergmann Anthony
CHIEF FINANCIAL OFFICER · Stock Option (Right to Buy) · 2026-06-24
Exercise400
Krasney Karen
EVP, GENERAL COUNSEL · Stock Option (Right to Buy) · 2026-06-24
Exercise400
Bergmann Anthony
CHIEF FINANCIAL OFFICER · Common Stock · 2026-06-24
Sell400
Bergmann Anthony
CHIEF FINANCIAL OFFICER · Common Stock · 2026-06-22
Exercise500
Bergmann Anthony
CHIEF FINANCIAL OFFICER · Stock Option (Right to Buy) · 2026-06-22
Exercise500
Krasney Karen
EVP, GENERAL COUNSEL · Common Stock · 2026-06-22
Exercise500
Krasney Karen
EVP, GENERAL COUNSEL · Common Stock · 2026-06-22
Sell500

SEC filings

EDGAR filings in CAPR · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.